SpaceX stock climbed 7% to $150.84 as investors positioned ahead of Starship test 14, the next flight of the company's fully reusable rocket standing about 400 feet tall. However, the enthusiasm comes with significant downside risk, as the test represents a make-or-break moment for the company's plan to retire its Falcon 9 rocket.

The buying spree is concentrated in two specific names within the Elon Musk ecosystem. Tesla stock jumped 7% to $381.69 on autonomy optimism and its manufacturing ties to SpaceX, while the broader space sector barely moved. The Procure Space ETF (UFO) rose just 0.2%, and the S&P 500 ETF Trust (SPY) climbed 1%, confirming Thursday's bid was a two-name trade rather than a sector-wide rotation into space.

SpaceX has run hard into the pending test. The stock was up 23% over the past month through the prior close, extending momentum from strong Q2 2026 results. The company reported revenue of $7.81 billion versus $6.82 billion estimated, and a backlog of $47.5 billion. More impressively, AI segment revenue reached $2.56 billion, up 247% year over year, and Starlink subscribers doubled to 12 million.

Why Are Investors Betting on SpaceX and Tesla Together?

The connection between SpaceX and Tesla runs deeper than shared leadership. SpaceX confirmed on August 6 plans for Terafab, a semiconductor project jointly backed with Tesla, with an initial commitment of $16.8 billion and at least 3,000 employees. ARK Invest estimated Terafab could eventually require $1 trillion in total investment, surpassing the inflation-adjusted $704 billion cost of the U.S. Interstate Highway System.

Beyond semiconductors, the two companies are intertwined across multiple business lines. Tesla holds a $2 billion SpaceX equity stake and partners on the semiconductor fab. Starlink is being integrated into Cybercab and other Tesla vehicles. Terafab is designed as a chip foundry meant to feed Optimus production and future AI hardware, tying manufacturing risk between the two companies.

SpaceX also disclosed plans to invest $100 billion in Starbase, Louisiana, in Vermilion Parish, with construction starting in 2027 and first launch targeted as early as 2029. To support these massive infrastructure plays, SpaceX founder Elon Musk acquired mobile power provider APR Energy for $1 billion, a business operating more than one gigawatt of deployable gas and diesel generation capacity.

What Could Go Wrong With This Rally?

The bear case is worth noting. Tesla's Q2 non-GAAP earnings per share came in at $0.33 versus $0.54 estimated, a significant miss. Free cash flow turned negative at negative $1.09 billion, raising questions about the company's ability to fund its ambitious plans.

If Starship test 14 disappoints, both names could give back the same-day gains quickly. Prediction markets on Polymarket assign a 0.9 probability that SpaceX stock finishes higher, a bullish tilt that has already priced in a lot of good news. The binary event risk cuts against the day's enthusiasm even as the capital commitments stack up.

How to Evaluate the Risk in This Trade

• Monitor the Test Window: No confirmed launch date has been published for Starship test 14, so the event sits in an approaching window rather than a scheduled one. Watch for FAA notices and official SpaceX announcements for timing clarity.
• Track Capital Deployment: Follow progress on Terafab site work in Grimes County, Texas, and Robotaxi expansion beyond its current seven U.S. metros. These projects will determine whether the $1 trillion Terafab estimate is realistic.
• Watch Cash Flow Trends: Tesla's negative free cash flow in Q2 is a red flag. Monitor quarterly cash flow reports to see whether the company can sustain its capital-intensive plans without additional financing.
• Size Positions Carefully: Given the binary launch risk sitting on top of already large capital plans, investors sizing their positions across the two names may want to keep their space-ecosystem exposure moderate.

Rocket Lab, the third player in the space sector, is the outlier. The stock was up just 1% at $63.66 despite record Q2 revenue of $234.07 million and a $2.36 billion backlog, up 137% year over year. The Neutron medium-lift rocket is targeting Q4 2026 delivery to launch pad, but today's narrow enthusiasm shows buyers are focused on Musk-linked catalysts rather than launch beta.

The Starship test window and any FAA notices could shape the next leg for SpaceX. Tesla holders can watch for follow-through on Terafab site work and Robotaxi expansion. For investors, the key question is whether the runway justifies the run, or whether the market has already priced in too much good news ahead of a test that remains unscheduled.